Owen N. Witte
Director, Kite Pharma.
Companies
- Allogene Therapeutics, Inc.Board member Oct 10, 2018 to now1
- Kite PharmaBoard member Mar 16, 2017 to Oct 5, 20172
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Allogene Therapeutics, Inc. ALLO292,832 shares3$375.4K at $1.28Jun 13, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 13, 2023Granted 74,561 shares of Allogene Therapeutics, Inc.3
- Aug 12, 2022Sold 5,000 shares at $17.25 of Allogene Therapeutics, Inc.4
- Aug 12, 2022Sold 5,000 shares at $17.25 of Allogene Therapeutics, Inc.5
- Aug 11, 2022Sold 10,000 shares at $16.50 of Allogene Therapeutics, Inc.4
- Aug 11, 2022Sold 10,000 shares at $16.50 of Allogene Therapeutics, Inc.5
- Jun 22, 2022Sold 10,000 shares at $11.76 of Allogene Therapeutics, Inc.6
- Jun 15, 2022Granted 22,089 shares of Allogene Therapeutics, Inc.7
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARKite Pharma, Board member
- 3
- 4SEC EDGARForm 4 filed Aug 15, 2022
- 5SEC EDGARForm 4 filed Aug 15, 2022
- 6SEC EDGARForm 4 filed Jun 23, 2022
- 7SEC EDGARForm 4 filed Jun 17, 2022